Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Impact of beta-blocker medication use on prostate cancer survival: Results from a single-institution cancer registry.
Kohli, Manish , Nandy, Debashis, Tan, Winston , Tindall, Donald J., Pathak, Jyotishman , Breitenstein, Matthew K. , Kohli, Manish , Haley, Charlotte, Lee, Adam , Cerhan, James R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e16064-e16064

10.1200/jco.2014.32.15_suppl.e16064 Get It

Immunologic activity of an activating anti-CD27 antibody (CDX-1127) in patients (pts) with solid tumors.
Infante, Jeffrey R., Burris, Howard A. , Ansell, Stephen M. , Villalobos, Víctor M. , Šikić, Branimir I. , Northfelt, Donald W. , Pilja, Lana, Hawthorne, Thomas, Davis, Thomas A. , Keler, Tibor , Nemunaitis, John , Weiss, Geoffrey R. , Taylor, Matthew H. , Carson, William E. , Yellin, Michael , Bullock, Timothy N J

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3027-3027

10.1200/jco.2014.32.15_suppl.3027 Get It

Phase I evaluation of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies.
Ansell, Stephen M. , Northfelt, Donald W. , Burris, Howard A. , Dinner, Shira, Villalobos, Víctor M. , Šikić, Branimir I. , Pilja, Lana, Hawthorne, Thomas, Keler, Tibor , Davis, Thomas A., Flinn, Ian W. , Taylor, Matthew H. , Yellin, Michael , Davis, Thomas A.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3024-3024

10.1200/jco.2014.32.15_suppl.3024 Get It

Aurora-A mitotic kinase and induction of endocrine resistance through downregulation of erα expression in initially erα+ breast cancer cells.
Salisbury, Jeffrey L., Zhang, Shuya , Hawse, John R. , Haddad, Tufia C. , D’Assoro, Antonino B. , Opyrchal, Mateusz , McCubrey, James Andrew , Goetz, Matthew P. , Degnim, Amy C. , Lange, Carol Ann , Ingle, James N. , Galanis, Evanthia

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 2568-2568

10.1200/jco.2014.32.15_suppl.2568 Get It

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).
Bernath, Albert M., Northfelt, Donald W. , Hou, Xiaonan , Tenner, Kathleen , Tienchaiananda, Piyawan , Flickinger, Lynn M. , Chen, Beiyun, Chen, Helen X., Lingle, Wilma L., Pellegrino, Christine, Sponzo, Robert W., Reinholz, Monica M., Perez, Edith A. , Haluska, Paul , Ballman, Karla V. , Dueck, Amylou C. , Linden, Hannah M. , Goetz, Matthew P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 632-632

10.1200/jco.2014.32.15_suppl.632 Get It

Genes associated with serum estrone, estrone conjugates, and androstenedione concentrations in postmenopausal women with estrogen receptor-positive breast cancer.
Dudenkov, Tanda M., Buzdar, Aman U. , Kubo, Michiaki , Batzler, Anthony , Jenkins, Gregory D. , Pietrzak, Tracy L., Northfelt, Donald W. , Perez, Edith A. , Williard, Clark, Nakamura, Yusuke , Wang, Liewei , Weinshilboum, Richard M. , Ingle, James N. , Robson, Mark E. , Carlson, Erin E. , Fridley, Brooke L. , Goetz, Matthew P. , Kalari, Krishna R. , Weinshilboum, Richard M.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 593-593

10.1200/jco.2014.32.15_suppl.593 Get It

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
Sweeney, Christopher, Liu, Glenn , Jarrard, David Frasier, Eisenberger, Mario A. , Wong, Yu‐Ning, Hahn, Noah M. , Cooney, Matthew M. , Shevrin, Daniel H. , García, Jorge A. , DiPaola, Robert S. , Chen, Yu‐Hui , Carducci, Michael A. , Kohli, Manish , Vogelzang, Nicholas J. , Dreicer, Robert , Picus, Joel , Hussain, Maha

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA2-LBA2

10.1200/jco.2014.32.15_suppl.lba2 Get It

Randomized multicenter phase II trial of timed-sequential therapy with flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus “7+3” for adults with newly diagnosed acute myeloid leukemia (AML).
Litzow, Mark R. , Morris, Lawrence E. , Levy, Moshe , Gojo, Ivana , Gocke, Christopher D. , Rosner, Gary L. , Greer, Jacqueline M., Cain, Joan McFadden, Little, Richard F. , Wright, John Joseph, Doyle, L. Austin, Karp, Judith E. , Zeidner, Joshua F. , Foster, Matthew C , Blackford, Amanda , Strickland, Stephen Anthony , Lancet, Jeffrey E. , Bose, Prithviraj , Tibes, Raoul , Smith, B. Douglas

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 7002-7002

10.1200/jco.2014.32.15_suppl.7002 Get It

Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts.
Sommeijer, Dirkje W. , Saad, Everardo D. , Coart, Elisabeth , Meyers, Jeffrey P., Seymour, Michel , Goldberg, Richard M. , Douillard, Jean‐Yves , Punt, Cornelis J. A. , Tournigand, Christophe , Chibaudel, Benoist , Gramont, Aimery de , group, for the ARCAD, Seymour, Matthew T , Shi, Qian , Buyse, Marc , Burzykowski, Tomasz , Maughan, Tim , Adams, Richard , Saltz, Leonard B. , Schmoll, Hans‐Joachim , Sargent, Daniel J. , Zalcberg, John , group, for the ARCAD, Chibaudel, Benoist

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3538-3538

10.1200/jco.2014.32.15_suppl.3538 Get It